https://nccn.digitellinc.com/p/s/exhibits-and-general-poster-session-22
https://nccn.digitellinc.com/p/s/challenging-case-review-breast-cancer-27
https://nccn.digitellinc.com/p/s/surgical-management-of-testicular-germ-cell-tumors-32
https://nccn.digitellinc.com/p/s/helping-cancer-survivors-return-to-work-37
https://nccn.digitellinc.com/p/s/management-of-metastatic-castration-resistant-prostate-cancer-42
https://nccn.digitellinc.com/p/s/effects-of-white-and-brown-bagging-on-oncology-practice-47
https://nccn.digitellinc.com/p/s/break-exhibits-and-general-poster-session-52
https://nccn.digitellinc.com/p/s/keynote-session-strategies-for-prevention-and-control-of-hpv-associated-cancers-57
https://nccn.digitellinc.com/p/s/break-exhibits-and-general-poster-session-62
https://nccn.digitellinc.com/p/s/nccn-guidelines-r-update-her2-positive-breast-cancer-67
https://nccn.digitellinc.com/p/s/screening-diagnosis-and-management-of-hereditary-renal-cell-carcinoma-72
https://nccn.digitellinc.com/p/s/updates-in-the-management-of-gastrointestinal-stromal-tumors-77
https://nccn.digitellinc.com/p/s/best-practices-for-incorporating-patient-reported-outcomes-into-oncology-care-82
https://nccn.digitellinc.com/p/s/nccn-guidelines-r-update-gastric-and-esophageal-cancers-87
https://nccn.digitellinc.com/p/s/nccn-guidelines-r-update-triple-negative-breast-cancer-92
https://nccn.digitellinc.com/p/s/non-ce-exhibitor-showcase-an-overview-of-cll-and-the-use-of-a-targeted-agent-for-previous-untreated-or-rr-cll-97
https://nccn.digitellinc.com/p/s/exhibits-and-general-poster-session-102
https://nccn.digitellinc.com/p/s/advances-in-oncofertility-fertility-preservation-options-for-adolescents-and-young-adults-with-cancer-107
https://nccn.digitellinc.com/p/s/challenging-case-review-colorectal-cancer-112
https://nccn.digitellinc.com/p/s/treatment-updates-in-acute-myeloid-leukemia-117
https://nccn.digitellinc.com/p/s/supportive-care-in-head-and-neck-cancers-multidisciplinary-management-122
https://nccn.digitellinc.com/p/s/new-settings-for-immune-checkpoint-inhibitors-in-urothelial-bladder-cancer-127
https://nccn.digitellinc.com/p/s/nccn-guidelines-c-update-multiple-myeloma-132
https://nccn.digitellinc.com/p/s/break-exhibits-and-general-poster-session-137
https://nccn.digitellinc.com/p/s/keynote-session-reducing-racial-disparities-in-oncology-recommendation-for-implementing-guideline-adherent-cancer-care-142
https://nccn.digitellinc.com/p/s/break-exhibits-and-general-poster-session-147
https://nccn.digitellinc.com/p/s/nccn-guidelines-c-update-uterine-cancers-152
https://nccn.digitellinc.com/p/s/treatment-of-locally-advanced-colorectal-cancer-157
https://nccn.digitellinc.com/p/s/updates-in-the-management-of-cllsll-management-of-relapsedrefractory-disease-and-the-role-of-minimal-residual-disease-162
https://nccn.digitellinc.com/p/s/advanced-thyroid-carcinoma-evolving-systemic-therapy-options-167
https://nccn.digitellinc.com/p/s/use-of-parp-inhibitors-for-ovarian-cancer-172
https://nccn.digitellinc.com/p/s/new-systemic-treatment-options-for-hepatobiliary-cancers-177
https://nccn.digitellinc.com/p/s/updates-on-car-t-cell-therapy-for-relapsedrefractory-b-cell-lymphomas-182
https://nccn.digitellinc.com/p/s/evolving-treatment-options-for-salivary-gland-tumors-187
https://nccn.digitellinc.com/p/s/non-ce-exhibitor-showcase-zejula-niraparib-educational-event-192
https://nccn.digitellinc.com/p/s/exhibits-and-general-postersession-197
https://nccn.digitellinc.com/p/s/challenging-case-review-non-small-cell-lung-cancer-202
https://nccn.digitellinc.com/p/s/updates-in-oncology-oral-presentations-from-the-nccn-poster-session-207
https://nccn.digitellinc.com/p/s/the-role-of-advanced-practice-providers-in-oncology-care-212
https://nccn.digitellinc.com/p/s/break-exhibits-and-general-poster-session-217
https://nccn.digitellinc.com/p/s/keynote-session-effects-of-the-pandemic-on-cancer-carefuture-directions-of-cancer-care-222
https://nccn.digitellinc.com/p/s/break-exhibits-and-general-poster-session-227
https://nccn.digitellinc.com/p/s/non-small-cell-lung-cancer-biomarker-testing-recommendations-232
https://nccn.digitellinc.com/p/s/cutaneous-melanoma-managment-of-melanoma-brain-metastases-237
https://nccn.digitellinc.com/p/s/importance-of-primary-care-physician-involvement-in-cancer-care-242
https://nccn.digitellinc.com/p/s/new-targeted-therapies-and-immunotherapies-for-metastatic-non-small-cell-lung-cancer-247
https://nccn.digitellinc.com/p/s/molecular-testing-for-cutaneous-melanoma-252
https://nccn.digitellinc.com/p/s/non-ce-exhibitor-showcase-a-treatment-option-for-patients-with-myelodysplastic-syndromes-257
https://nccn.digitellinc.com/p/s/thursday-concurrent-block-1-264
https://nccn.digitellinc.com/p/s/thursday-concurrent-block-2-272
https://nccn.digitellinc.com/p/s/friday-concurrent-block-1-279
https://nccn.digitellinc.com/p/s/friday-concurrent-block-2-287
https://nccn.digitellinc.com/p/s/friday-concurrent-block-3-294
https://nccn.digitellinc.com/p/s/saturday-concurrent-block-1-303
https://nccn.digitellinc.com/p/s/saturday-concurrent-block-2-313
https://nccn.digitellinc.com/p/s/virtual-exhibition-hall-322
https://nccn.digitellinc.com/p/s/updates-in-the-management-of-newly-diagnosed-acute-myeloid-leukemia-324
https://nccn.digitellinc.com/p/s/debate-response-milestones-that-matter-in-chronic-myeloid-leukemia-mmr-vs-ccyr-329
https://nccn.digitellinc.com/p/s/break-and-virtual-exhibition-hall-334
https://nccn.digitellinc.com/p/s/patient-case-studies-and-panel-discussion-leukemias-339
https://nccn.digitellinc.com/p/s/break-and-virtual-exhibition-hall-344
https://nccn.digitellinc.com/p/s/mutational-landscape-in-myeloproliferative-neoplasms-implications-on-prognosis-and-clinical-management-349
https://nccn.digitellinc.com/p/s/recommendations-for-managing-adults-with-histiocytic-neoplasms-new-nccn-guidelines-r-354
https://nccn.digitellinc.com/p/s/non-ce-exhibitor-showcase-updates-to-long-term-data-for-tafasitamab-in-combination-with-lenalidomide-for-nte-rr-dlbcl-patients-359
https://nccn.digitellinc.com/p/s/virtual-exhibition-hall-364
https://nccn.digitellinc.com/p/s/newly-diagnosed-multiple-myeloma-how-many-drugs-are-enough-369
https://nccn.digitellinc.com/p/s/maneuvering-the-complex-web-of-treatment-options-for-relapsedrefractory-multiple-myeloma-374
https://nccn.digitellinc.com/p/s/break-and-virtual-exhibition-hall-379
https://nccn.digitellinc.com/p/s/patient-case-studies-and-panel-discussion-plasma-cell-neoplasms-384
https://nccn.digitellinc.com/p/s/virtual-exhibition-hall-389
https://nccn.digitellinc.com/p/s/optimizing-treatment-approaches-for-chronic-lymphocytic-leukemiasmall-lymphocytic-lymphoma-394
https://nccn.digitellinc.com/p/s/minimal-residual-disease-assessment-in-chronic-lymphocytic-leukemiasmall-lymphocytic-leukemia-is-it-ready-for-routine-clinical-practice-399
https://nccn.digitellinc.com/p/s/non-ce-exhibitor-showcase-evolving-treatment-approaches-in-mds-and-cmml-404
https://nccn.digitellinc.com/p/s/updates-in-the-management-of-early-stage-diffuse-large-b-cell-lymphoma-409
https://nccn.digitellinc.com/p/s/diffuse-large-b-cell-lymphoma-optimizing-therapy-for-relapsedrefractory-disease-414
https://nccn.digitellinc.com/p/s/break-and-virtual-exhibition-hall-419
https://nccn.digitellinc.com/p/s/patient-case-studies-and-panel-discussion-lymphomas-424
https://nccn.digitellinc.com/p/s/break-and-virtual-exhibition-hall-429
https://nccn.digitellinc.com/p/s/mantle-cell-lymphoma-updates-in-the-management-of-relapsedrefractory-disease-434
https://nccn.digitellinc.com/p/s/optimizing-first-line-therapy-for-advanced-stage-classic-hodgkin-lymphoma-439
https://nccn.digitellinc.com/p/s/non-ce-exhibitor-showcase-use-of-a-targeted-agent-for-previously-untreated-or-rr-cll-444
https://nccn.digitellinc.com/p/s/virtual-exhibition-hall-445
https://nccn.digitellinc.com/p/s/geneticfamilial-risk-assessment-for-breast-cancer-testing-considerations-and-controversies-457
https://nccn.digitellinc.com/p/s/impact-of-the-pandemic-on-breast-cancer-screening-462
https://nccn.digitellinc.com/p/s/break-467
https://nccn.digitellinc.com/p/s/locoregional-management-of-non-metastatic-breast-cancer-with-sabcs-updates-472
https://nccn.digitellinc.com/p/s/break-477
https://nccn.digitellinc.com/p/s/neoadjuvant-and-adjuvant-treatment-for-breast-cancer-with-sabcs-updates-482
https://nccn.digitellinc.com/p/s/management-of-metastatic-breast-cancer-with-sabcs-updates-487
https://nccn.digitellinc.com/p/s/break-492
https://nccn.digitellinc.com/p/s/managing-pain-and-neuropathy-in-breast-cancer-survivors-497
https://nccn.digitellinc.com/p/s/patient-case-studies-and-panel-discussion-management-of-acute-lymphoblastic-leukemia-860
https://nccn.digitellinc.com/p/s/new-treatment-options-and-toxicity-management-in-acute-lymphoblastic-leukemia-861
https://nccn.digitellinc.com/p/s/treating-acute-myeloid-leukemia-in-2022-evolving-concepts-and-management-strategies-862
https://nccn.digitellinc.com/p/s/management-of-systemic-amyloidosis-863
https://nccn.digitellinc.com/p/s/treatment-decisions-in-multiple-myeloma-864
https://nccn.digitellinc.com/p/s/how-to-incorporate-immunotherapies-in-the-management-of-multiple-myeloma-865
https://nccn.digitellinc.com/p/s/the-importance-of-re-vaccination-after-cellular-therapy-866
https://nccn.digitellinc.com/p/s/treatment-decisions-in-chronic-lymphocytic-leukemiasmall-lymphocytic-lymphoma-867
https://nccn.digitellinc.com/p/s/optimizing-treatment-for-relapsedrefractory-mantle-cell-lymphoma-868
https://nccn.digitellinc.com/p/s/debate-transplant-vs-car-t-cell-therapy-in-relapsedrefractory-diffuse-large-b-cell-lymphoma-869
https://nccn.digitellinc.com/p/s/echelon-1-do-updated-results-change-the-first-line-treatment-of-stage-iii-iv-classical-hodgkin-lymphoma-870
https://nccn.digitellinc.com/p/s/management-of-advanced-systemic-mastocytosis-871
https://nccn.digitellinc.com/p/s/familialgenetic-leukemia-syndromes-impact-on-patient-care-872
https://nccn.digitellinc.com/p/s/hematopoietic-growth-factors-use-of-thrombopoietin-receptor-agonists-in-patients-with-cancer-873
https://nccn.digitellinc.com/p/s/management-of-chronic-phase-chronic-myeloid-leukemia-with-resistance-to-multiple-tkis-874
https://nccn.digitellinc.com/p/s/managing-cardiovascular-events-in-multiple-myeloma-875
https://nccn.digitellinc.com/p/s/emerging-treatment-options-for-myelodysplastic-syndromes-876
https://nccn.digitellinc.com/p/s/management-of-polycythemia-vera-and-essential-thrombocythemia-877
https://nccn.digitellinc.com/p/s/implementation-of-a-hematology-outpatient-sepsis-alert-protocol-881
https://nccn.digitellinc.com/p/s/palliative-care-and-hematologic-malignancies-can-they-co-exist-882
https://nccn.digitellinc.com/p/s/key-assessment-and-evaluation-strategies-after-car-t-cell-therapy-883
https://nccn.digitellinc.com/p/s/updates-in-the-management-of-graft-versus-host-disease-884
https://nccn.digitellinc.com/p/s/non-ce-presentation-pivotal-phase-3-data-in-newly-diagnosed-aml-885
https://nccn.digitellinc.com/p/s/registration-breakfast-and-exhibits-886
https://nccn.digitellinc.com/p/s/break-and-exhibits-887
https://nccn.digitellinc.com/p/s/break-and-exhibits-888
https://nccn.digitellinc.com/p/s/welcome-reception-889
https://nccn.digitellinc.com/p/s/registration-breakfast-and-exhibits-890
https://nccn.digitellinc.com/p/s/break-and-exhibits-891
https://nccn.digitellinc.com/p/s/lunch-and-exhibits-892
https://nccn.digitellinc.com/p/s/registration-and-lunch-893
https://nccn.digitellinc.com/p/s/break-894
https://nccn.digitellinc.com/p/cf/speaker-management-test-895
https://nccn.digitellinc.com/p/s/nccn-poster-presentation-xyz-896
https://nccn.digitellinc.com/p/s/breakfast-exhibits-registration-and-general-poster-session-899
https://nccn.digitellinc.com/p/s/hereditaryfamilial-ovarian-cancer-testing-principles-and-risk-management-900
https://nccn.digitellinc.com/p/s/management-of-relapsedrefractory-multiple-myeloma-901
https://nccn.digitellinc.com/p/s/management-of-metastatic-prostate-cancer-902
https://nccn.digitellinc.com/p/s/updates-on-the-management-of-immunotherapy-related-toxicities-903
https://nccn.digitellinc.com/p/s/break-exhibits-and-general-poster-session-904
https://nccn.digitellinc.com/p/s/plenary-session-health-system-recruitment-and-retention-strategies-905
https://nccn.digitellinc.com/p/s/lunch-exhibits-and-general-poster-session-906
https://nccn.digitellinc.com/p/s/non-ce-exhibitor-showcase-multi-cancer-early-detection-through-multi-biomarker-liquid-biopsy-testing-907
https://nccn.digitellinc.com/p/s/management-of-advanced-ovarian-fallopian-tube-and-primary-peritoneal-cancers-908
https://nccn.digitellinc.com/p/s/mobile-screening-programs-improving-patient-access-to-oncology-care-909
https://nccn.digitellinc.com/p/s/advances-in-the-management-of-metastatic-breast-cancer-910
https://nccn.digitellinc.com/p/s/programs-to-reduce-hospital-admissions-and-readmissions-911
https://nccn.digitellinc.com/p/s/break-exhibits-and-general-poster-session-912
https://nccn.digitellinc.com/p/s/challenging-case-review-breast-cancer-913
https://nccn.digitellinc.com/p/s/sexual-identity-and-function-in-patients-with-cancer-and-survivors-914
https://nccn.digitellinc.com/p/s/nccn-foundation-young-investigator-awards-oral-poster-presentation-915
https://nccn.digitellinc.com/p/s/welcome-reception-916
https://nccn.digitellinc.com/p/s/breakfast-exhibits-and-general-poster-session-917
https://nccn.digitellinc.com/p/s/emerging-therapies-in-the-treatment-of-bladder-cancer-918
https://nccn.digitellinc.com/p/s/nccn-guidelines-r-update-chronic-lymphocytic-leukemiasmall-lymphocytic-lymphoma-919
https://nccn.digitellinc.com/p/s/screening-for-lung-cancer-an-expert-review-920
https://nccn.digitellinc.com/p/s/updates-in-the-systemic-therapy-options-for-clear-and-non-clear-cell-renal-cell-carcinoma-921
https://nccn.digitellinc.com/p/s/break-exhibits-and-general-poster-session-922
https://nccn.digitellinc.com/p/s/plenary-session-best-practices-for-addressing-the-health-needs-of-the-lgbtq-plus-community-in-oncology-care-923
https://nccn.digitellinc.com/p/s/lunch-exhibits-and-general-poster-session-924
https://nccn.digitellinc.com/p/s/non-ce-exhibitor-showcase-expanded-horizons-a-post-endocrine-option-for-patients-with-hr-plus-her2-mbc-925
https://nccn.digitellinc.com/p/s/cancer-screening-in-underrepresented-populations-926
https://nccn.digitellinc.com/p/s/the-implementation-science-of-patient-reported-outcomes-927
https://nccn.digitellinc.com/p/s/targeted-therapy-for-metastatic-non-small-cell-lung-cancer-928
https://nccn.digitellinc.com/p/s/social-determinants-of-health-collection-integration-and-intervention-929
https://nccn.digitellinc.com/p/s/break-exhibits-and-general-poster-session-930
https://nccn.digitellinc.com/p/s/challenging-case-review-non-small-cell-lung-cancer-931
https://nccn.digitellinc.com/p/s/new-patient-access-programs-932
https://nccn.digitellinc.com/p/s/updates-in-oncology-oral-presentations-from-the-nccn-poster-sessions-933
https://nccn.digitellinc.com/p/s/breakfast-934
https://nccn.digitellinc.com/p/s/management-of-pain-in-patients-with-cancer-935
https://nccn.digitellinc.com/p/s/neoadjuvant-treatment-approaches-for-stage-ii-iii-rectal-cancer-936
https://nccn.digitellinc.com/p/s/prophylaxis-for-cancer-associated-venous-thromboembolic-disease-937
https://nccn.digitellinc.com/p/s/updates-in-the-management-of-hepatobiliary-cancers-938
https://nccn.digitellinc.com/p/s/break-939
https://nccn.digitellinc.com/p/s/nccn-guidelines-r-for-central-nervous-system-cancers-updates-in-the-treatment-of-adult-patients-with-glioma-940
https://nccn.digitellinc.com/p/s/updates-in-the-treatment-of-metastatic-colorectal-cancer-941
https://nccn.digitellinc.com/p/s/plenary-session-sleep-disorders-fatigue-and-cognitive-function-in-cancer-survivors-942
https://nccn.digitellinc.com/p/s/management-of-recurrent-or-metastatic-cervical-cancer-943
https://nccn.digitellinc.com/p/s/new-first-line-systemic-treatment-options-for-metastatic-esophageal-squamous-cell-carcinoma-944
https://nccn.digitellinc.com/p/s/radiation-therapy-for-metastatic-brain-tumors-945
https://nccn.digitellinc.com/p/s/breakfast-and-registration-946
https://nccn.digitellinc.com/p/s/providing-access-to-cancer-care-in-historically-marginalized-communities-lessons-learned-from-dana-farbers-cancer-care-equity-program-947
https://nccn.digitellinc.com/p/s/operational-excellence-for-inpatient-rounding-948
https://nccn.digitellinc.com/p/s/break-949
https://nccn.digitellinc.com/p/s/updates-in-biomarker-testing-in-non-small-cell-lung-cancer-950
https://nccn.digitellinc.com/p/s/new-challenges-in-the-management-of-pulmonary-toxicities-951
https://nccn.digitellinc.com/p/s/management-of-acute-hyperglycemia-952
https://nccn.digitellinc.com/p/s/lunch-953
https://nccn.digitellinc.com/p/s/early-involvement-of-palliative-care-in-cancer-treatment-954
https://nccn.digitellinc.com/p/s/harm-reduction-strategies-for-substance-use-in-patients-with-cancer-955
https://nccn.digitellinc.com/p/s/concurrent-block-958
https://nccn.digitellinc.com/p/s/concurrent-block-959
https://nccn.digitellinc.com/p/s/concurrent-block-960
https://nccn.digitellinc.com/p/s/concurrent-block-961
https://nccn.digitellinc.com/p/s/concurrent-block-962
https://nccn.digitellinc.com/p/s/concurrent-block-963
https://nccn.digitellinc.com/p/s/concurrent-block-964
https://nccn.digitellinc.com/p/s/concurrent-block-965
https://nccn.digitellinc.com/p/s/concurrent-block-966
https://nccn.digitellinc.com/p/s/concurrent-block-967
https://nccn.digitellinc.com/p/s/concurrent-block-968
https://nccn.digitellinc.com/p/s/concurrent-block-969
https://nccn.digitellinc.com/p/s/concurrent-block-970
https://nccn.digitellinc.com/p/s/targeting-nkg2d-ligands-is-therapeutically-effective-in-nsclc-979
https://nccn.digitellinc.com/p/s/evolutionary-pressures-shape-soft-tissue-sarcoma-development-and-response-to-radiotherapy-980
https://nccn.digitellinc.com/p/s/cd19-car-t-cells-develop-exhaustion-epigenetic-programs-during-a-clinical-response-981
https://nccn.digitellinc.com/p/s/non-melanoma-skin-cancer-nmsc-in-patients-with-chronic-lymphocytic-leukemia-cll-biology-and-prevention-982
https://nccn.digitellinc.com/p/s/early-interim-analysis-of-a-phase-ii-randomized-trial-of-moderate-versus-ultrahypofractionated-post-prostatectomy-radiation-therapy-983
https://nccn.digitellinc.com/p/s/be-epic-behavioral-economic-interventions-to-embed-palliative-care-in-community-oncology-984
https://nccn.digitellinc.com/p/s/do-proton-pump-inhibitors-affect-the-effectiveness-of-capecitabine-based-chemotherapy-in-colorectal-cancers-a-systematic-review-with-meta-analysis-985
https://nccn.digitellinc.com/p/s/cervical-cancer-screening-among-the-rural-indians-a-community-based-prospective-study-986
https://nccn.digitellinc.com/p/s/disparities-in-outcomes-of-chemotherapy-related-febrile-neutropenia-patients-a-nationwide-study-of-hospitalizations-987
https://nccn.digitellinc.com/p/s/total-neoadjuvant-chemotherapy-followed-by-hipec-and-curative-surgery-in-treatment-of-locally-advanced-gastric-cancer-988
https://nccn.digitellinc.com/p/s/real-world-study-of-disease-free-survival-and-associated-patient-characteristics-in-early-stage-non-small-cell-lung-cancer-nsclc-a-retrospective-observational-study-989
https://nccn.digitellinc.com/p/s/real-world-egfr-testing-in-patients-with-surgically-resected-stage-i-iii-non-small-cell-lung-cancer-nsclc-in-us-community-oncology-practices-990
https://nccn.digitellinc.com/p/s/prevalence-of-substance-use-in-cancer-patients-at-a-5-year-difference-a-cross-sectional-study-from-nationally-representative-population-991
https://nccn.digitellinc.com/p/s/laparoscopic-complete-mesocolic-excision-versus-standard-laparoscopic-right-hemicolectomy-in-egyptian-right-colon-cancer-992
https://nccn.digitellinc.com/p/s/positive-quality-intervention-in-action-implementation-and-value-in-practice-993
https://nccn.digitellinc.com/p/s/using-nccn-distress-thermometer-to-screen-cancer-patients-on-an-inpatient-oncology-unit-994
https://nccn.digitellinc.com/p/s/evaluating-the-clinical-significance-of-clonal-hematopoiesis-of-indeterminate-potential-chip-in-patients-with-breast-and-non-small-cell-lung-cancer-nsclc-995
https://nccn.digitellinc.com/p/s/characterizing-opioid-prescribing-trends-of-medical-oncologists-from-2013-2019-996
https://nccn.digitellinc.com/p/s/comparison-of-outcomes-using-nccn-classification-in-two-concurrent-phase-iii-trials-in-intermediate-and-high-risk-prostate-cancer-long-term-data-998
https://nccn.digitellinc.com/p/s/hydrogel-slope-and-optimization-of-prostate-rectal-hydrogel-placement-999
https://nccn.digitellinc.com/p/s/racial-differences-in-outcomes-of-osimertinib-in-patients-with-egfr-positive-non-small-cell-lung-cancer-in-a-real-world-us-population-1001
https://nccn.digitellinc.com/p/s/accelerating-adoption-of-hypofractionation-in-breast-cancer-through-clinical-pathways-and-peer-review-1002
https://nccn.digitellinc.com/p/s/patient-satisfaction-with-electronic-health-records-results-from-a-survey-of-morrocan-patients-in-mohammed-vi-oncology-center-1003
https://nccn.digitellinc.com/p/s/improving-multidisciplinary-thoracic-tumor-board-with-a-case-submission-tool-1004
https://nccn.digitellinc.com/p/s/demographic-changes-of-expanded-2021-lung-cancer-screening-guidelines-in-a-large-national-database-1005
https://nccn.digitellinc.com/p/s/impact-of-the-covid-pandemic-on-oncology-education-mentorship-and-networking-a-national-survey-1006
https://nccn.digitellinc.com/p/s/mc200402-single-arm-phase-2-study-of-the-fgfr-inhibitor-futibatinib-in-combination-with-pembrolizumab-in-patients-with-fgf19-expressing-advanced-or-metastatic-hepatocellular-carcinoma-1007
https://nccn.digitellinc.com/p/s/evaluation-of-patients-with-multiple-egfr-genomic-tests-in-the-metastatic-nsclc-setting-1008
https://nccn.digitellinc.com/p/s/committing-to-resiliency-transforming-burnout-to-resilience-at-a-national-cancer-institute-nci-comprehensive-cancer-center-1009
https://nccn.digitellinc.com/p/s/real-world-analysis-examining-cost-of-early-disease-progression-among-patients-with-epidermal-growth-factor-receptor-mutated-metastatic-non-small-cell-lung-cancer-1010
https://nccn.digitellinc.com/p/s/treatment-of-her2-plus-breast-cancer-a-retrospective-of-disease-prognosis-with-loss-of-her2-amplification-on-residual-disease-after-neoadjuvant-treatment-in-a-community-hospital-setting-1012
https://nccn.digitellinc.com/p/s/lung-cancer-treatment-utilization-trends-2019-2021-1013
https://nccn.digitellinc.com/p/s/a-retrospective-review-of-myelodysplastic-syndrome-management-mds-at-watson-clinic-llp-from-diagnosis-to-primary-course-of-treatment-1014
https://nccn.digitellinc.com/p/s/why-did-560-azerbaijan-population-women-have-de-novo-stage-iv-breast-cancer-1015
https://nccn.digitellinc.com/p/s/the-diagnostic-value-of-intraoperative-ultrasonography-for-the-diagnosis-of-colorectal-cancer-liver-metastases-1016
https://nccn.digitellinc.com/p/s/expression-of-pd-l1-through-evolution-phase-from-pre-invasive-to-invasive-lung-adenocarcinoma-1017
https://nccn.digitellinc.com/p/s/a-rare-case-of-intratubular-cytoplasmic-al-amyloidosis-in-a-patient-without-multiple-myeloma-1018
https://nccn.digitellinc.com/p/s/the-role-of-smad4tgfv-signaling-in-the-tumor-progression-from-intraductal-papillary-mucinous-neoplasia-ipmn-to-pancreatic-ductal-adenocarcinoma-pdac-1019
https://nccn.digitellinc.com/p/s/aligning-nccn-criteria-with-testing-workflows-using-a-novel-database-application-criterion-1022
https://nccn.digitellinc.com/p/s/electrocardiographic-findings-in-cancer-patients-receiving-chemotherapy-from-the-colombian-coffee-triangle-region-1023
https://nccn.digitellinc.com/p/s/cardiovascular-event-risk-following-androgen-deprivation-therapy-initiation-by-personal-history-of-cardiovascular-events-1024
https://nccn.digitellinc.com/p/s/optimal-interval-between-immune-therapy-and-targeted-therapy-with-sotorasib-in-patients-with-kras-g12c-mutant-non-small-cell-lung-cancer-1026
https://nccn.digitellinc.com/p/s/electronic-cigarette-exposure-on-the-growth-and-metastasis-of-oral-squamous-cell-carcinoma-1028
https://nccn.digitellinc.com/p/s/a-prospective-interventional-study-to-assess-the-response-of-systemic-chemotherapy-in-aggressive-recurrent-giant-cell-tumor-1029
https://nccn.digitellinc.com/p/s/covid-19-impact-and-psychosocial-well-being-among-adults-living-with-cancer-a-longitudinal-analysis-1030
https://nccn.digitellinc.com/p/s/pooled-outcomes-of-anti-braf-agents-in-advanced-stage-colorectal-cancer-1031
https://nccn.digitellinc.com/p/s/the-benefits-of-a-clinically-based-individualized-exercise-oncology-program-on-health-care-utilization-in-patients-with-malignancies-1032
https://nccn.digitellinc.com/p/s/health-related-quality-of-life-in-patients-with-metastatic-basal-cell-carcinoma-treatedwith-cemiplimab-analysis-of-a-phase-2-open-label-clinical-trial-1033
https://nccn.digitellinc.com/p/s/extensive-and-dynamic-signs-and-symptoms-prior-to-cancer-diagnoses-1034
https://nccn.digitellinc.com/p/s/ivosidenib-as-a-novel-treatment-for-patients-with-isocitrate-dehydrogenase-1-positive-advanced-colon-cancer-1035
https://nccn.digitellinc.com/p/s/reasons-for-lung-cancer-patients-to-present-to-the-ed-1036
https://nccn.digitellinc.com/p/s/can-telemedicine-use-affect-oncologists-workload-in-the-arab-world-1037
https://nccn.digitellinc.com/p/s/the-potential-clinical-impact-of-a-multi-cancer-early-detection-test-for-individuals-with-missing-cancer-stage-information-1038
https://nccn.digitellinc.com/p/s/a-novel-semi-supervised-learning-algorithm-for-prognosis-oriented-classification-and-biomarker-identification-of-colorectal-cancer-1039
https://nccn.digitellinc.com/p/s/an-unusual-case-presentation-of-severe-idiopathic-multicentric-castleman-disease-imcd-1040
https://nccn.digitellinc.com/p/s/baseline-neutrophil-to-lymphocyte-ratio-and-its-change-over-time-predict-overall-survival-in-metastatic-non-small-cell-lung-cancer-patients-who-received-first-line-pembrolizumab-therapy-1041
https://nccn.digitellinc.com/p/s/characteristics-and-outcomes-of-patients-treated-with-selpercatinib-in-the-real-world-a-retrospective-study-using-us-claims-databases-1042
https://nccn.digitellinc.com/p/s/diagnosis-of-metastatic-non-small-cell-lung-cancer-during-hospitalization-missed-opportunity-for-optimal-supportive-care-1043
https://nccn.digitellinc.com/p/s/improving-management-of-treatment-side-effects-through-chemotherapy-care-kit-delivery-in-vietnam-1044
https://nccn.digitellinc.com/p/s/nurse-navigators-charted-a-course-for-equitable-care-in-multiple-myeloma-simplifying-qi-to-measure-the-impact-of-accredited-education-1045
https://nccn.digitellinc.com/p/s/real-world-use-of-neratinib-in-patients-with-her2-positive-early-stage-breast-cancer-following-prior-ado-trastuzumab-emtansine-t-dm1-or-dual-her2-blockade-with-pertuzumab-plus-trastuzumab-1046
https://nccn.digitellinc.com/p/s/pancreatic-cancer-the-impact-of-early-connectivity-and-coordination-of-care-on-retention-and-time-to-treat-1047
https://nccn.digitellinc.com/p/s/risk-factors-and-prognosis-of-stroke-in-gynecologic-cancer-1048
https://nccn.digitellinc.com/p/s/patient-awareness-of-elevated-breast-cancer-risk-after-routine-screening-mammogram-and-risk-notification-1049
https://nccn.digitellinc.com/p/s/how-pancreatic-patients-choose-their-cancer-center-an-analysis-of-factors-that-influence-retention-1050
https://nccn.digitellinc.com/p/s/real-world-data-on-the-implementation-of-a-hereditary-hematological-myeloid-malignancy-workflow-experience-of-a-single-academic-medical-center-1051
https://nccn.digitellinc.com/p/s/an-app-run-lymphadenopathy-clinic-the-cleveland-clinic-experience-1071
https://nccn.digitellinc.com/p/s/uterine-cancer-uc-on-the-rise-in-the-united-states-us-one-of-the-largest-racial-disparities-in-oncology-1072
https://nccn.digitellinc.com/p/s/do-ehr-embedded-clinical-decision-support-tools-reduce-variation-in-care-a-pre-and-post-implementation-comparison-of-regimen-ordering-variation-at-a-multi-site-community-cancer-clinic-1073
https://nccn.digitellinc.com/p/s/analyzing-trends-in-the-incidence-and-mortality-of-esophageal-cancer-in-the-united-states-a-15-year-population-based-study-1074
https://nccn.digitellinc.com/p/s/precision-oncology-integrating-structured-genomic-data-into-the-electronic-health-record-via-the-epic-r-genomics-module-1075
https://nccn.digitellinc.com/p/s/oncologists-perceptions-of-a-novel-superoxide-dismutase-mimetic-avasopasem-manganese-for-treating-severe-oral-mucositis-in-patients-with-locally-advanced-head-and-neck-cancer-1076
https://nccn.digitellinc.com/p/s/the-impact-of-dysbiosis-agents-on-the-effectiveness-of-immune-checkpoint-inhibitors-in-advanced-melanoma-patients-a-systematic-review-with-meta-analysis-1077
https://nccn.digitellinc.com/p/s/safety-profile-of-sonic-hedgehog-inhibitors-in-basal-cell-carcinoma-a-systematic-review-1078
https://nccn.digitellinc.com/p/s/outcomes-of-patients-with-pancreatic-cancer-undergoing-duodenal-stent-placement-a-population-based-study-1079
https://nccn.digitellinc.com/p/s/oral-cancer-screening-among-the-rural-indians-a-community-based-prospective-study-1080
https://nccn.digitellinc.com/p/s/does-anemia-contribute-to-increased-risk-of-adverse-outcomes-in-cancer-patients-with-venous-thromboembolism-a-longitudinal-study-from-national-representative-population-1081
https://nccn.digitellinc.com/p/s/volatile-organic-compounds-released-by-gastric-tissues-as-potential-biomarkers-of-gastric-cancer-1082
https://nccn.digitellinc.com/p/s/surviving-the-odds-socioeconomic-disparities-in-her2-plus-breast-cancer-with-brain-metastases-and-chemotherapy-a-seer-analysis-1083
https://nccn.digitellinc.com/p/s/real-world-dosing-patterns-in-patients-with-anaplastic-lymphoma-kinase-positive-alk-plus-non-small-cell-lung-cancer-nsclc-treated-with-brigatinib-in-the-front-linefl-setting-in-the-united-states-a-cla-1084
https://nccn.digitellinc.com/p/s/improving-hematology-oncology-education-in-internal-medicine-residency-a-single-institution-quality-improvement-project-1085
https://nccn.digitellinc.com/p/s/real-world-study-of-biomarker-testing-and-treatment-patterns-in-patients-with-metastatic-castration-resistant-prostate-cancer-in-the-united-states-us-a-physician-survey-1086
https://nccn.digitellinc.com/p/s/update-from-the-dedalo-protocol-an-integrated-approach-to-mrd-in-cll-patients-receiving-venetoclax-plus-rituximab-1087
https://nccn.digitellinc.com/p/s/using-the-electronic-health-record-ehr-to-capture-structured-oncology-data-in-real-time-at-the-point-of-care-a-mayo-clinic-comprehensive-cancer-center-mcccc-pilot-study-1088
https://nccn.digitellinc.com/p/s/the-role-of-mirna-21-and-mirna-101-in-diagnosis-prognosis-and-survival-of-laryngeal-cancer-1089
https://nccn.digitellinc.com/p/s/physician-preferences-on-biomarker-testing-in-newly-diagnosed-metastatic-nsclc-patients-who-had-insufficient-tumor-tissue-1090
https://nccn.digitellinc.com/p/s/real-world-combination-use-of-mogamulizumab-with-other-therapies-among-patients-with-mycosis-fungoides-and-sezary-syndrome-1091
https://nccn.digitellinc.com/p/s/non-squamous-metastatic-non-small-cell-lung-cancer-retrospective-c-met-overexpression-testing-patient-characteristics-and-treatment-patterns-1092
https://nccn.digitellinc.com/p/s/immune-checkpoint-inhibitor-ici-treatment-after-progression-on-anti-pd-1-therapy-in-advanced-melanoma-a-systematic-review-of-the-literature-1093
https://nccn.digitellinc.com/p/s/creating-a-fellowship-curriculum-clinical-trial-patient-conversations-1094
https://nccn.digitellinc.com/p/s/bimodal-distribution-of-osteosarcoma-a-thing-of-the-past-comparative-analysis-from-surveillance-epidemiology-and-end-results-seer-and-national-inpatient-sample-nis-1095
https://nccn.digitellinc.com/p/s/risk-of-second-malignancy-among-non-metastatic-seminoma-patients-treated-with-radiation-therapy-and-chemotherapy-in-manitoba-1096
https://nccn.digitellinc.com/p/s/disease-burden-and-treatment-patterns-in-patients-diagnosed-with-her2-metastatic-gastricgastroesophageal-junction-cancer-mggejc-1097
https://nccn.digitellinc.com/p/s/patient-and-provider-perspectives-on-how-covid-19-impacted-melanoma-care-delivery-1098
https://nccn.digitellinc.com/p/s/health-care-satisfaction-among-cancer-patients-undergoing-radiotherapy-a-tunisian-center-experience-1099
https://nccn.digitellinc.com/p/s/an-app-initiated-telehealth-visit-to-reduce-oncology-patient-readmissions-lessons-learned-1100
https://nccn.digitellinc.com/p/s/clinical-characteristics-and-outcomes-of-us-extensive-stage-small-cell-lung-cancer-es-sclc-patients-not-receiving-guideline-preferred-regimens-1101
https://nccn.digitellinc.com/p/s/evaluation-of-a-standardized-approach-to-hypersensitivityinfusion-reaction-management-in-a-large-ambulatory-oncology-center-1102
https://nccn.digitellinc.com/p/s/the-impact-of-tailored-lean-approach-in-optimization-of-infusion-scheduling-process-in-an-nci-designated-cancer-center-1103
https://nccn.digitellinc.com/p/s/the-influence-of-operability-status-on-outcomes-in-patients-with-t4a-larynx-cancer-an-institutional-experience-1104
https://nccn.digitellinc.com/p/s/stress-related-biofeedback-responses-after-reiki-and-sound-healing-therapies-for-breast-cancer-survivors-1105
https://nccn.digitellinc.com/p/s/targeted-axillary-dissection-post-primary-chemotherapy-data-analysis-from-a-single-multidisciplinary-unit-in-south-africa-1106
https://nccn.digitellinc.com/p/s/emotional-and-mental-health-support-needs-of-adolescent-and-young-adult-aya-colorectal-cancer-patients-1107
https://nccn.digitellinc.com/p/s/real-world-study-of-first-line-treatment-patterns-in-hr-plus-her2-metastatic-breast-cancer-mbc-at-a-tertiary-care-cancer-institute-1108
https://nccn.digitellinc.com/p/s/hdr-icr-brachytherapy-with-solo-anesthesia-administration-as-a-resource-effective-and-patient-safe-method-in-cancer-cervix-1109
https://nccn.digitellinc.com/p/s/a-race-against-time-in-cancer-diagnosis-a-qi-study-1110
https://nccn.digitellinc.com/p/s/the-frequency-of-androgen-receptor-splice-variant-7-ar-v7-in-solid-tumors-1111
https://nccn.digitellinc.com/p/s/first-line-1l-systemic-therapy-in-patients-pts-with-advanced-non-small-cell-lung-cancer-ansclc-at-community-settings-in-the-united-states-us-1112
https://nccn.digitellinc.com/p/s/assessment-of-physician-treatment-preferences-for-relapsed-or-refractory-rr-diffuse-large-b-cell-lymphoma-dlbcl-1113
https://nccn.digitellinc.com/p/s/digital-multidisciplinary-meetings-enable-regional-specialist-oncology-treatment-1114
https://nccn.digitellinc.com/p/s/extranodal-presentation-of-double-hit-high-grade-b-cell-lymphoma-1115
https://nccn.digitellinc.com/p/s/tissue-and-liquid-biopsy-utilization-in-advanced-nsclc-in-a-large-community-us-practice-1116
https://nccn.digitellinc.com/p/s/real-world-duration-of-venetoclax-treatment-for-chronic-lymphocytic-leukemia-and-small-lymphocytic-leukemia-cllsll-1117
https://nccn.digitellinc.com/p/s/mutational-landscape-in-concurrent-and-sequential-cases-of-lymphoid-malignancy-and-cmml-1118
https://nccn.digitellinc.com/p/s/real-world-frequency-of-echo-monitoring-and-incidence-of-anti-her2-therapy-related-cardiac-events-in-her2-plus-breast-cancer-patients-1119
https://nccn.digitellinc.com/p/s/quality-improvement-using-a-multi-modal-approach-in-addressing-identified-barriers-to-improve-lung-cancer-screening-in-northeast-georgia-an-interim-report-1120
https://nccn.digitellinc.com/p/s/evaluation-of-adding-neck-dissection-to-n0-head-and-neck-cancer-patients-1121
https://nccn.digitellinc.com/p/s/tumor-transcriptomic-profile-in-patients-pts-with-synchronous-versus-metachronous-metastatic-clear-cell-renal-cell-carcinoma-mccrcc-1122
https://nccn.digitellinc.com/p/s/predictors-of-delay-for-initial-oncology-referral-and-treatment-at-a-safety-net-hospital-a-single-center-analysis-1123
https://nccn.digitellinc.com/p/s/adding-virtual-reality-mindful-exposure-therapy-to-a-cancer-centers-tobacco-treatment-offerings-an-acceptability-pilot-study-1124
https://nccn.digitellinc.com/p/s/real-world-observations-show-beneficial-outcomes-in-patients-with-nsclc-treated-with-pembrolizumab-for-more-than-2-years-1125
https://nccn.digitellinc.com/p/s/assessment-of-sustained-mrd-negativity-and-reversion-in-real-world-multiple-myeloma-patients-using-ngs-clonoseq-assay-1126
https://nccn.digitellinc.com/p/s/disparities-in-prostate-cancer-survival-outcomes-in-appalachian-kentucky-1127
https://nccn.digitellinc.com/p/s/supporting-the-capture-of-structured-data-for-patients-with-cancer-using-cancer-specific-note-templates-1128
https://nccn.digitellinc.com/p/s/pediatric-metastatic-pulmonary-adenocarcinoma-1129
https://nccn.digitellinc.com/p/s/knowing-the-lymphomas-of-the-legal-amazon-how-do-they-differ-1130
https://nccn.digitellinc.com/p/s/pd-1pd-l1-inhibitors-in-advanced-and-metastatic-esophageal-carcinoma-an-updated-meta-analysis-of-randomized-controlled-trials-1131
https://nccn.digitellinc.com/p/s/dosimetric-comparison-of-hypofractionation-with-concomitant-boost-versus-sequential-boost-following-breast-conserving-surgery-in-early-stage-breast-cancer-patients-1132
https://nccn.digitellinc.com/p/s/comparison-of-modified-patient-reported-paper-g8-and-epic-g4-plus-4-with-clinician-reported-standard-g8-to-screen-frailty-in-older-patients-with-cancer-1133
https://nccn.digitellinc.com/p/s/risk-of-secondary-malignancies-after-platinum-based-chemotherapy-in-testicular-seminoma-patients-a-population-based-study-1134
https://nccn.digitellinc.com/p/s/elevation-in-the-creatinine-with-niraparib-true-or-false-1136
https://nccn.digitellinc.com/p/s/patient-level-barriers-to-the-global-care-for-familial-adenomatous-polyposis-lessons-from-a-large-brazilian-family-1137
https://nccn.digitellinc.com/p/s/perceived-risk-and-uptake-of-healthy-lifestyle-behaviors-for-breast-cancer-prevention-among-high-risk-women-1138
https://nccn.digitellinc.com/p/s/frequency-of-hereditary-cancer-syndromes-in-pediatric-patients-experience-in-a-tertiary-care-childrens-hospital-in-mexico-1139
https://nccn.digitellinc.com/p/s/interventional-pain-management-in-outpatient-setting-for-cancer-patients-a-review-of-literature-1140
https://nccn.digitellinc.com/p/s/conventional-hydration-versus-short-hydration-for-reducing-chemotherapy-induced-nephrotoxicity-cin-among-adult-esophageal-cancer-patients-at-uganda-cancer-institute-mbarara-uganda-an-interventional-st-1141
https://nccn.digitellinc.com/p/s/race-and-gender-specific-trends-of-mortality-from-hepatocellular-carcinoma-in-the-united-states-1999-2020-1142
https://nccn.digitellinc.com/p/s/dosimetric-assessment-of-3-dimensions-radiotherapy-3d-rt-and-intensity-modulated-radiotherapy-imrt-for-flank-irradiation-in-pediatric-patients-with-wilms-tumor-benefit-risk-balance-1143
https://nccn.digitellinc.com/p/s/electronic-health-record-alerts-compared-to-chart-review-for-lung-cancer-screening-eligibility-1144
https://nccn.digitellinc.com/p/s/effectiveness-and-toxicity-of-cetuximab-with-concurrent-rt-in-locally-advanced-cutaneous-squamous-cell-skin-cancer-a-case-series-1145
https://nccn.digitellinc.com/p/s/incidence-and-mechanisms-of-coexisting-hematological-malignancies-chronic-lymphocytic-leukemia-and-chronic-myeloid-leukemia-a-retrospective-review-1146
https://nccn.digitellinc.com/p/s/non-ce-exhibitor-showcase-an-overview-of-clinical-data-for-enhertu-fam-trastuzumab-deruxtecan-nxki-in-her2-expressing-metastatic-breast-cancer-1147
https://nccn.digitellinc.com/p/s/non-ce-exhibitor-showcase-the-poseidon-regimen-imfinzi-r-durvalumab-plus-imjudo-r-tremelimumab-actl-and-platinum-based-chemotherapy-1148
https://nccn.digitellinc.com/p/s/continue-the-conversation-1149
https://nccn.digitellinc.com/p/s/follow-the-expert-guided-poster-tour-1150
https://nccn.digitellinc.com/p/s/continue-the-conversation-1151
https://nccn.digitellinc.com/p/s/non-ce-exhibitor-showcase-herpes-zoster-in-immunocompromised-populations-1152
https://nccn.digitellinc.com/p/s/continue-the-conversation-1153
https://nccn.digitellinc.com/p/s/follow-the-expert-guided-poster-tour-1154
https://nccn.digitellinc.com/p/s/non-ce-exhibitor-showcase-personalizing-treatment-for-adult-patients-with-advanced-nsclc-1155
https://nccn.digitellinc.com/p/s/continue-the-conversation-1156
https://nccn.digitellinc.com/p/s/welcome-1176
https://nccn.digitellinc.com/p/s/analyzing-trends-in-the-incidence-and-mortality-of-esophageal-cancer-in-the-united-states-a-15-year-population-based-study-1177
https://nccn.digitellinc.com/p/s/registration-refreshments-and-exhibits-1363
https://nccn.digitellinc.com/p/s/non-ce-product-theater-learn-about-a-different-approach-to-btk-inhibition-1364
https://nccn.digitellinc.com/p/s/revolutionizing-hematologic-cancer-treatment-the-promise-of-bispecific-t-cell-engagers-1365
https://nccn.digitellinc.com/p/s/navigating-the-challenges-effective-management-of-toxicities-in-car-t-cell-therapies-1366
https://nccn.digitellinc.com/p/s/break-and-exhibits-1367
https://nccn.digitellinc.com/p/s/adult-acute-lymphocytic-leukemia-strategies-for-selection-of-consolidation-therapy-1368
https://nccn.digitellinc.com/p/s/acute-myeloid-leukemia-selecting-induction-therapy-based-on-biological-disease-factors-1369
https://nccn.digitellinc.com/p/s/case-studies-in-the-management-of-leukemia-1370
https://nccn.digitellinc.com/p/s/welcome-reception-and-exhibits-1371
https://nccn.digitellinc.com/p/s/registration-breakfast-and-exhibits-1372
https://nccn.digitellinc.com/p/s/non-ce-product-theater-an-advancement-in-frontline-dlbcl-1373
https://nccn.digitellinc.com/p/s/navigating-change-best-practices-for-integrating-whoicc-classification-systems-in-the-management-of-hematologic-malignancies-1374
https://nccn.digitellinc.com/p/s/management-of-newly-diagnosed-multiple-myeloma-based-on-risk-stratification-1375
https://nccn.digitellinc.com/p/s/incorporating-immunotherapeutic-strategies-in-the-management-of-relapsedrefractory-multiple-myeloma-1376
https://nccn.digitellinc.com/p/s/break-and-exhibits-1377
https://nccn.digitellinc.com/p/s/tackling-inequities-in-multiple-myeloma-practical-steps-for-improving-access-and-quality-of-care-1378
https://nccn.digitellinc.com/p/s/advances-in-the-management-of-classical-hodgkin-lymphoma-1379
https://nccn.digitellinc.com/p/s/lunch-and-exhibits-1380
https://nccn.digitellinc.com/p/s/non-ce-product-theater-understanding-the-role-of-advanced-practice-providers-in-the-management-of-low-risk-myelodysplastic-syndromes-mds-1381
https://nccn.digitellinc.com/p/s/perioperative-management-of-anticoagulation-and-antithrombotic-therapy-1382
https://nccn.digitellinc.com/p/s/updates-in-the-management-of-mantle-cell-lymphoma-is-there-still-a-role-for-transplant-1383
https://nccn.digitellinc.com/p/s/break-and-exhibits-1384
https://nccn.digitellinc.com/p/s/relapsedrefractory-cllsll-overcoming-resistance-to-covalent-btki-andor-bcl2-inhibitors-1385
https://nccn.digitellinc.com/p/s/management-of-toxicities-of-btk-inhibitors-in-b-cell-malignancies-1386
https://nccn.digitellinc.com/p/s/bone-disease-management-and-infections-in-multiple-myeloma-1387
https://nccn.digitellinc.com/p/s/chronic-myeloid-leukemiamyelofibrosis-tki-therapy-and-toxicity-management-1388
https://nccn.digitellinc.com/p/s/management-of-graft-versus-host-disease-in-hematopoietic-cell-transplant-recipients-1389
https://nccn.digitellinc.com/p/s/management-of-lower-risk-myelodysplastic-syndromes-1390
https://nccn.digitellinc.com/p/s/management-of-waldenstrom-macroglobulinemia-1391
https://nccn.digitellinc.com/p/s/updates-in-the-management-of-myelofibrosis-1392
https://nccn.digitellinc.com/p/cf/2024-annual-conference-poster-hall-1398
https://nccn.digitellinc.com/p/s/spatial-evolution-of-immune-cell-dysfunction-during-development-of-oligometastatic-renal-cell-carcinoma-1402
https://nccn.digitellinc.com/p/s/patients-perspectives-on-being-treated-by-multiple-care-teams-for-autologous-transplantcar-t-eligible-lymphoma-and-multiple-myeloma-1403
https://nccn.digitellinc.com/p/s/a-phase-i-study-of-tas102-plus-talazoparib-in-advanced-colorectal-crc-and-esophagogastric-egc-adenocarcinomas-1404
https://nccn.digitellinc.com/p/s/genetic-ancestry-and-genomic-alterations-of-cervical-cancer-in-a-diverse-patient-population-1405
https://nccn.digitellinc.com/p/s/the-nf-ia-transcription-factor-is-a-hif-independent-oncogenic-dependency-in-kidney-cancer-1406
https://nccn.digitellinc.com/p/s/mait-cells-are-reduced-in-anorectal-mucosal-melanomas-compared-to-cutaneous-melanoma-gi-metastases-1407
https://nccn.digitellinc.com/p/s/liquid-biomarkers-of-response-to-radium-223-in-metastatic-prostate-cancer-1408
https://nccn.digitellinc.com/p/s/does-routine-clinical-assessment-of-older-adults-with-gastroesophageal-cancer-tell-the-whole-story-1409
https://nccn.digitellinc.com/p/s/comparative-assessment-of-social-determinants-of-health-in-community-and-academic-hospitals-for-patients-diagnosed-with-hepatocellular-carcinoma-1410
https://nccn.digitellinc.com/p/s/implementation-of-an-integrated-supportive-care-medicine-consultation-service-within-a-gastrointestinal-cancer-clinic-timeliness-of-referrals-and-patient-access-1411
https://nccn.digitellinc.com/p/s/dynamic-changes-in-circulating-tumor-dna-predicts-disease-progression-or-regression-in-colorectal-cancer-1412
https://nccn.digitellinc.com/p/s/microwave-ablation-versus-resection-versus-stereotactic-body-radiation-therapy-ofstage-ia-non-small-cell-lung-cancer-in-us-veterans-1413
https://nccn.digitellinc.com/p/s/a-safety-net-system-for-significant-diagnostic-imaging-actionable-findings-at-a-comprehensive-cancer-care-center-1414
https://nccn.digitellinc.com/p/s/immune-checkpoint-inhibitor-induced-type-1-diabetes-mellitus-patient-characteristics-clinical-outcomes-and-survival-implications-of-autoantibodies-1415
https://nccn.digitellinc.com/p/s/development-of-heart-failure-following-anthracycline-exposure-in-survivors-of-adolescent-and-young-adult-cancer-in-an-integrated-healthcare-system-1416
https://nccn.digitellinc.com/p/s/hierarchical-multimodal-learning-on-pan-squamous-cell-carcinomas-for-improved-survival-outcomes-1417
https://nccn.digitellinc.com/p/s/share-the-fear-communication-concerns-of-parents-with-cancer-with-dependent-children-for-their-co-parent-a-qualitative-study-1418
https://nccn.digitellinc.com/p/s/aneuploid-epcam-plus-disseminated-tumor-cells-dtcs-correlated-with-liver-metastasis-and-independently-predict-poor-survival-in-small-cell-lung-cancer-1419
https://nccn.digitellinc.com/p/s/real-world-outcomes-in-patients-with-burkitt-lymphoma-in-a-safety-net-health-system-1420
https://nccn.digitellinc.com/p/s/surviving-and-thriving-after-lung-cancer-a-pilot-project-to-understand-physician-perspectives-on-the-approach-to-lung-cancer-survivorship-care-at-weill-cornell-medicine-medical-oncology-1421
https://nccn.digitellinc.com/p/s/personalizing-the-patient-experience-understanding-the-emotional-state-and-learning-preferences-of-pancreatic-cancer-patients-receiving-multidisciplinary-care-1422
https://nccn.digitellinc.com/p/s/real-world-clinical-benefit-among-patients-with-lower-risk-myelodysplastic-syndromes-treated-with-luspatercept-1423
https://nccn.digitellinc.com/p/s/prior-sars-cov-2-in-patients-with-car-t-negatively-impacts-overall-survival-highlighting-the-need-for-targeted-prophylaxis-strategies-1424
https://nccn.digitellinc.com/p/s/estimation-of-impact-of-care-gap-on-patient-outcome-and-healthcare-cost-burden-using-real-world-data-in-early-stage-nsclc-an-empirical-study-for-delay-in-surgery-1425
https://nccn.digitellinc.com/p/s/patient-reported-outcome-pro-data-in-oncology-ndas-approved-by-the-fda-2018-2021-a-review-of-criticism-and-concerns-in-comments-from-regulators-1426
https://nccn.digitellinc.com/p/s/impact-of-social-determinantssdoh-on-surgery-and-patient-outcomes-in-early-stagenon-small-cell-lung-cancer-ensclc-1427
https://nccn.digitellinc.com/p/s/predicting-disparities-in-adverse-dispositions-following-major-surgery-for-lung-cancer-using-machine-learning-1428
https://nccn.digitellinc.com/p/s/lung-cancer-in-never-smokers-the-role-of-radon-exposure-and-public-knowledge-1429
https://nccn.digitellinc.com/p/s/educational-efficacy-of-youtube-videos-on-multiple-myeloma-1430
https://nccn.digitellinc.com/p/s/development-and-pilot-testing-of-a-comprehensive-set-of-measures-for-organizational-assessment-of-nccn-guideline-recommended-genomic-testing-1431
https://nccn.digitellinc.com/p/s/utilization-of-biomarker-testing-and-biomarker-driven-targeted-therapy-among-patientswith-metastatic-non-small-cell-lung-cancer-1432
https://nccn.digitellinc.com/p/s/mesothelioma-trends-in-palliative-care-utilization-in-hospitalized-patients-a-national-inpatient-sample-nis-study-2016-2020-1433
https://nccn.digitellinc.com/p/s/instituting-quality-improvement-processes-with-periprocedural-heparin-infusions-at-a-major-cancer-center-utilizing-a-failure-mode-and-effects-analysis-1434
https://nccn.digitellinc.com/p/s/high-dose-rate-interstitial-brachytherapy-for-squamous-cell-carcinoma-of-the-vaginamethods-and-outcomes-at-a-single-institution-1435
https://nccn.digitellinc.com/p/s/comparing-cancer-risk-management-between-females-with-truncating-chek2-1100delc-versus-missense-chek2-i157t-variants-1436
https://nccn.digitellinc.com/p/s/overall-survival-os-impact-for-nsclc-patients-with-irae-and-non-irae-hospital-admissions-during-first-line-pembrolizumab-treatment-1437
https://nccn.digitellinc.com/p/s/joining-forces-to-minimize-hypomagnesemia-in-patients-receiving-cisplatin-and-cetuximab-infusions-1438
https://nccn.digitellinc.com/p/s/combining-immunotherapy-and-anti-angiogenesis-remodeling-the-immune-microenvironment-of-lkb1keap1-mutant-non-small-cell-lung-cancer-1439
https://nccn.digitellinc.com/p/s/microfluidic-characterization-and-analysis-of-circulating-tumor-cells-from-patients-with-metastatic-melanoma-1440
https://nccn.digitellinc.com/p/s/pneumonitis-incidences-in-metastatic-non-small-cell-lung-cancer-on-immunotherapy-a-systematic-review-and-meta-analysis-1441
https://nccn.digitellinc.com/p/s/a-mindfulness-based-intervention-for-caregivers-of-autologous-hematopoietic-stem-cell-transplant-patients-pilot-study-results-1442
https://nccn.digitellinc.com/p/s/a-national-cancer-data-base-ncdb-analysis-of-prognostic-factors-in-metastatic-triple-negative-breast-cancer-tnbc-1443
https://nccn.digitellinc.com/p/s/disparities-in-real-world-screening-mammography-compliance-rates-by-body-mass-index-and-mobility-restricting-diagnosis-a-commercial-claims-based-analysis-1444
https://nccn.digitellinc.com/p/s/working-and-cancer-the-impact-of-cancer-diagnosis-and-treatment-on-employment-presenteeism-and-productivity-1445
https://nccn.digitellinc.com/p/s/treatment-patterns-in-surgically-resected-nsclc-since-the-introduction-of-immunooncology-agents-1446
https://nccn.digitellinc.com/p/s/the-impact-of-the-covid-19-pandemic-on-cancer-treatments-a-seer-population-based-analysis-1447
https://nccn.digitellinc.com/p/s/a-data-driven-approach-to-increase-lung-cancer-screening-rate-in-the-catchment-area-of-an-nci-designated-cancer-center-via-community-outreach-and-engagement-1448
https://nccn.digitellinc.com/p/s/early-diagnosis-of-cancer-cachexia-using-body-composition-index-as-the-radiographic-biomarker-1449
https://nccn.digitellinc.com/p/s/immune-cell-dynamics-after-radiotherapy-for-oligometastatic-prostate-cancer-1450
https://nccn.digitellinc.com/p/s/efficacy-of-fruquintinib-in-less-heavily-pretreated-patients-pts-with-metastatic-colorectal-cancer-mcrc-profile-matched-data-from-fresco-and-fresco-2-1451
https://nccn.digitellinc.com/p/s/demographics-and-outcomes-of-autologous-stem-cell-transplant-among-igd-multiple-myeloma-patients-1452
https://nccn.digitellinc.com/p/s/treatment-outcomes-in-vexas-syndrome-in-patients-with-mds-a-systematic-review-1453
https://nccn.digitellinc.com/p/s/single-cell-spatial-proteomics-reveals-the-heterogeneity-and-microenvironment-characteristics-of-long-term-survival-patients-of-small-cell-lung-cancer-1454
https://nccn.digitellinc.com/p/s/managing-pharmaceutical-costs-in-the-oncology-care-model-1455
https://nccn.digitellinc.com/p/s/the-impact-of-proton-pump-inhibitors-on-palbociclib-in-advanced-breast-cancer-patients-a-systematic-review-and-meta-analysis-1456
https://nccn.digitellinc.com/p/s/red-cell-distribution-width-and-putative-severity-markers-as-predictors-of-short-term-critical-illness-in-hospitalized-cancer-patients-1457
https://nccn.digitellinc.com/p/s/underserved-patients-find-their-voice-through-newly-formed-sclc-community-1458
https://nccn.digitellinc.com/p/s/contemporary-treatment-patterns-for-patients-diagnosed-with-ct1a-renal-tumors-a-national-cancer-database-study-1459
https://nccn.digitellinc.com/p/s/recommendation-and-genotyping-discrepancies-in-dpyd-for-oncology-patients-1460
https://nccn.digitellinc.com/p/s/compliance-with-recommendations-and-clinical-practices-increased-after-publication-of-the-japanese-clinical-practice-guidelines-for-pancreatic-cancer-2022-edition-1461
https://nccn.digitellinc.com/p/s/sociodemographic-trends-and-regional-disparities-associated-with-leukemia-in-florida-implications-of-an-aging-population-on-leukemia-incidences-and-mortalities-in-the-united-states-1462
https://nccn.digitellinc.com/p/s/prolonged-anesthesia-as-a-risk-factor-for-extended-length-of-stay-following-craniotomy-for-primary-glioma-1463
https://nccn.digitellinc.com/p/s/does-immunotherapy-work-in-patients-with-poor-performance-status-1464
https://nccn.digitellinc.com/p/s/optimizing-the-implementation-of-new-therapies-in-multiple-myeloma-1465
https://nccn.digitellinc.com/p/s/institutional-policy-implementation-for-allocating-chemotherapy-during-a-shortage-1466
https://nccn.digitellinc.com/p/s/impact-of-neoadjuvant-chemotherapy-on-survival-and-pathological-response-among-octogenarians-who-underwent-radical-cystectomy-for-muscle-invasive-bladder-cancer-1467
https://nccn.digitellinc.com/p/s/induction-chemotherapy-in-locally-advanced-squamous-cell-carcinoma-of-head-and-neck-biweekly-docetaxel-cisplatin-5-fluorouracil-leucovorin-tpfl-versus-triweekly-tpf-response-assessment-and-translation-1468
https://nccn.digitellinc.com/p/s/real-world-clinical-outcomes-of-first-line-therapies-and-treatment-regimens-for-braf-mutant-advancedmetastatic-melanoma-retrospective-observational-study-1469
https://nccn.digitellinc.com/p/s/treatment-patterns-and-blood-count-control-in-10112-patients-with-polycythemia-vera-managed-at-community-practices-in-the-united-states-1470
https://nccn.digitellinc.com/p/s/a-rare-case-of-extranodal-primary-gallbladder-lymphoma-presented-as-biliary-obstruction-and-treated-with-rituximab-and-lenalidomide-1471
https://nccn.digitellinc.com/p/s/a-best-evidence-based-practice-of-management-of-pruritus-to-anti-pd-1pd-l1-therapy-1472
https://nccn.digitellinc.com/p/s/a-comparison-of-somatic-mutations-and-eln-classification-in-de-novo-acute-myeloid-leukemia-between-appalachian-and-non-appalachian-kentucky-1473
https://nccn.digitellinc.com/p/s/pumping-iron-in-the-preoperative-period-is-it-beneficial-in-reducing-blood-transfusions-1474
https://nccn.digitellinc.com/p/s/rectal-cancer-disparities-in-age-and-overall-survival-among-american-indian-and-alaska-native-vs-non-hispanic-white-populations-1475
https://nccn.digitellinc.com/p/s/technologys-impact-on-implementing-the-nccn-distress-thermometer-in-a-community-based-oncology-clinic-1476
https://nccn.digitellinc.com/p/s/implementation-of-an-usg-peripheral-iv-placement-program-1477
https://nccn.digitellinc.com/p/s/organomegalies-as-a-predictive-indicator-of-leukemia-cutis-in-the-patients-with-acute-myeloid-leukemia-1478
https://nccn.digitellinc.com/p/s/real-world-treatment-patterns-and-effectiveness-of-selpercatinib-in-patients-with-locally-advancedmetastatic-non-small-cell-lung-cancer-in-the-us-1479
https://nccn.digitellinc.com/p/s/assessing-and-accrediting-molecular-tumor-boards-in-spain-mtbs-excellence-1480
https://nccn.digitellinc.com/p/s/impact-of-socioeconomic-status-on-cancer-care-in-southeast-texas-a-population-based-cohort-study-1481
https://nccn.digitellinc.com/p/s/community-oncologists-perceptions-on-the-evolving-role-of-surrogate-endpoints-in-oncologic-clinical-trials-1482
https://nccn.digitellinc.com/p/s/evaluation-of-the-reliability-of-mpmri-in-diagnosing-prostate-cancer-following-intravesical-bacillus-calmette-guerin-therapy-for-bladder-cancer-1483
https://nccn.digitellinc.com/p/s/reimagining-the-pathology-report-virtual-3d-specimen-mapping-in-oncologic-surgery-1484
https://nccn.digitellinc.com/p/s/patient-reported-outcome-measures-used-in-patients-with-chronic-phase-chronic-myeloid-leukemia-a-systematic-review-of-the-literature-1485
https://nccn.digitellinc.com/p/s/cemiplimab-use-in-advanced-cutaneous-squamous-cell-carcinoma-and-non-small-cell-lung-cancer-risk-factors-associated-with-mortality-1486
https://nccn.digitellinc.com/p/s/disparities-in-colorectal-cancer-mortality-outcomes-a-ten-year-trend-study-1487
https://nccn.digitellinc.com/p/s/quality-recommendations-for-the-management-of-cutaneous-squamous-cell-carcinoma-cscc-1488
https://nccn.digitellinc.com/p/s/hippocampal-optimization-and-dosimetric-analysis-on-feasibility-of-hippocampal-sparing-in-primary-gliomas-a-retrospective-dosimetric-study-in-a-tertiary-care-centre-1489
https://nccn.digitellinc.com/p/s/real-world-treatment-patterns-of-selumetinib-among-patients-with-neurofibromatosis-type-i-and-plexiform-neurofibroma-in-the-united-states-1490
https://nccn.digitellinc.com/p/s/relationship-between-durable-transfusion-independence-and-survival-outcomes-in-patients-with-lower-risk-myelodysplastic-syndrome-an-analysis-from-us-health-insurance-claims-data-1491
https://nccn.digitellinc.com/p/s/efficacy-of-selinexor-in-acute-myeloid-leukemia-a-systematic-review-and-meta-analysis-1492
https://nccn.digitellinc.com/p/s/the-role-of-social-determinants-of-health-in-gastrointestinal-cancer-outcomes-in-the-united-states-context-a-systematic-review-1493
https://nccn.digitellinc.com/p/s/place-of-death-from-cancer-in-episodic-value-based-care-models-in-a-community-oncology-network-1494
https://nccn.digitellinc.com/p/s/predicting-treatment-related-fatigue-in-the-context-of-lymphoma-and-chronic-lymphocytic-leukemia-1495
https://nccn.digitellinc.com/p/s/efficacy-of-a-mindfulness-based-stress-management-program-for-allogeneic-hct-caregivers-trial-in-progress-1496
https://nccn.digitellinc.com/p/s/trial-in-progress-a-multi-center-phase-i-trial-of-neratinib-and-fam-trastuzumab-deruxtecan-in-advanced-refractory-gastric-cancer-patients-1497
https://nccn.digitellinc.com/p/s/rheniumre-186-obisbemedare-186-nanoliposome-186rnlin-leptomeningeal-metastasis-lm-phase-12a-dose-escalation-trial-update-of-initial-safety-and-feasibility-through-cohorts-1-4-1498
https://nccn.digitellinc.com/p/s/revolutionizing-no-therapy-novel-no-generator-enhances-quality-of-life-and-cardiopulmonary-function-in-lung-cancer-patients-1499
https://nccn.digitellinc.com/p/s/role-of-99m-tc-dtpa-bischoline-in-evaluation-of-breast-cancer-a-prospective-diagnostic-trial-in-progress-at-aiims-rishikesh-1500
https://nccn.digitellinc.com/p/s/improved-access-through-an-integrated-supportive-care-model-reduced-urgent-care-referral-and-admission-rates-for-patients-with-gastrointestinal-malignancy-1501
https://nccn.digitellinc.com/p/s/comparing-apples-to-apples-in-uterine-cancer-racial-disparity-and-propensity-score-matching-1502
https://nccn.digitellinc.com/p/s/the-clinical-effect-of-a-community-based-genetic-testing-program-1503
https://nccn.digitellinc.com/p/s/results-from-the-phase-3-trial-of-imetelstat-a-first-in-class-telomerase-inhibitor-in-patients-with-red-blood-cell-transfusion-dependent-non-del5q-lower-risk-myelodysplastic-syndromes-relapsedrefracto-1504
https://nccn.digitellinc.com/p/s/biomarker-testing-surgical-outcomes-and-adjuvant-therapy-rates-among-patients-with-resected-non-small-cell-lung-cancer-nsclc-in-the-community-setting-in-the-united-states-us-2019-2023-1505
https://nccn.digitellinc.com/p/s/improving-anal-cancer-screening-a-comparative-analysis-of-high-risk-human-papillomavirus-tests-alone-or-in-combination-with-anal-cytology-assays-to-predict-high-grade-squamous-intraepithelial-lesions-1506
https://nccn.digitellinc.com/p/s/myeloid-sarcoma-in-a-patient-with-marfan-syndrome-1507
https://nccn.digitellinc.com/p/s/autonomic-symptoms-may-suggest-paraneoplastic-neurological-syndromes-in-small-cell-lung-cancer-1508
https://nccn.digitellinc.com/p/s/evaluating-and-improving-post-operative-vte-prophylaxis-in-patients-with-a-history-of-cancer-results-of-a-quality-improvement-initiative-in-a-community-hospital-setting-1509
https://nccn.digitellinc.com/p/s/a-cost-effective-noninvasive-multiomics-assay-bcdx-for-diagnostic-accuracy-of-bladder-cancer-compares-to-the-gold-standard-of-cytoscopy-and-cytology-1510
https://nccn.digitellinc.com/p/s/impact-of-somatic-mutations-on-outcomes-of-salvage-radiation-and-hormonal-therapy-for-prostate-cancer-recurrence-after-prostatectomy-1511
https://nccn.digitellinc.com/p/s/utilizing-the-five-as-model-in-radiation-oncology-patients-tobacco-cessation-1512
https://nccn.digitellinc.com/p/s/epigenetic-analysis-on-runx3-mislocalization-and-its-association-with-tumor-microenvironment-alteration-in-non-small-cell-lung-cancer-1513
https://nccn.digitellinc.com/p/s/reporting-the-false-negative-rate-of-sentinel-lymph-node-biopsy-for-melanoma-a-useful-quality-control-metric-1514
https://nccn.digitellinc.com/p/s/characteristics-of-individuals-and-genomic-testing-in-early-onset-gi-cancers-in-the-southeastern-us-1515
https://nccn.digitellinc.com/p/s/perceptions-of-cartitude-4-for-patients-with-relapsedrefractory-multiple-myeloma-1516
https://nccn.digitellinc.com/p/s/monitoring-concordance-of-chronic-lymphocytic-leukemia-cll-at-watson-clinic-llp-diagnosis-and-treatment-1517
https://nccn.digitellinc.com/p/s/real-world-treatment-tx-patterns-and-outcomes-for-first-line-1l-novel-hormonal-agent-nha-naive-metastatic-castration-resistant-prostate-cancer-mcrpc-including-in-black-andor-african-american-baa-patie-1518
https://nccn.digitellinc.com/p/s/re-evaluating-breast-cancer-screening-recommendations-an-analysis-of-breast-cancer-incidence-by-age-groups-1519
https://nccn.digitellinc.com/p/s/length-of-hospital-stay-unplanned-readmission-and-mortality-for-patients-treated-with-partial-nephrectomy-or-radical-nephrectomy-for-stage-i-and-ii-kidney-tumors-1520
https://nccn.digitellinc.com/p/s/non-optimal-treatment-in-early-line-patients-with-chronic-myeloid-leukemia-in-chronicphase-cml-cp-treated-with-tyrosine-kinase-inhibitors-tki-a-claims-data-analysis-1521
https://nccn.digitellinc.com/p/s/surgeon-administered-transversus-abdominis-plane-block-with-local-anesthetic-infiltration-versus-transversus-abdominis-plane-block-following-robot-assisted-radical-prostatectomy-1522
https://nccn.digitellinc.com/p/s/impact-of-frailty-on-hospital-outcomes-among-patients-with-hemophagocytic-lymphohistiocytosis-who-received-autologous-stem-cell-transplantation-in-the-united-states-1523
https://nccn.digitellinc.com/p/s/trends-in-the-incidence-and-mortality-of-metastatic-epidural-spinal-cord-compression-a-ten-year-population-based-study-1524
https://nccn.digitellinc.com/p/s/treatment-strategies-and-survival-outcomes-in-non-invasive-primary-urethral-cancer-a-comprehensive-analysis-from-a-large-database-1525
https://nccn.digitellinc.com/p/s/chemotherapy-induced-febrile-neutropenia-fn-in-the-us-healthcare-resourceutilization-hcru-and-costs-1526
https://nccn.digitellinc.com/p/s/bcg-refractory-non-muscle-invasive-bladder-cancer-treated-by-systemic-pembrolizumab-is-associated-with-discontinuation-due-to-adverse-effects-1527
https://nccn.digitellinc.com/p/s/standardizing-height-and-weight-measurement-for-treatment-calculations-in-adult-patients-with-cancer-1528
https://nccn.digitellinc.com/p/s/serum-pepsinogen-iii-in-patients-undergoing-esophagogastroduodenoscopy-and-biopsy-in-two-institutions-in-bogota-colombia-1529
https://nccn.digitellinc.com/p/s/the-effect-of-tbi-based-conditioning-regimen-on-recurrence-and-transplant-related-mortality-among-patients-with-mantle-cell-lymphoma-who-received-autologous-bone-marrow-transplant-1530
https://nccn.digitellinc.com/p/s/utilizing-diverse-enrollment-to-validate-the-delfi-fragmentome-test-for-advancing-lung-cancer-screening-1531
https://nccn.digitellinc.com/p/s/prostate-biopsies-against-medical-advice-unveiling-new-biomarker-insights-for-men-1532
https://nccn.digitellinc.com/p/s/utilization-of-exodx-prostate-test-for-prostate-cancer-risk-stratification-in-the-african-american-population-1533
https://nccn.digitellinc.com/p/s/plexus-brachialis-a-dosimetric-study-in-carcinoma-head-and-neck-treated-using-conformal-radiotherapy-1534
https://nccn.digitellinc.com/p/s/neoadjuvant-tyrosine-kinase-inhibitors-tkis-efficacy-in-egfr-positive-stage-iii-nonsmall-cell-lung-cancer-nsclc-a-systematic-review-and-meta-analysis-1535
https://nccn.digitellinc.com/p/s/determinants-of-quality-of-life-and-optimism-in-patients-with-egfr-mutated-advanced-non-small-cell-lung-cancer-1536
https://nccn.digitellinc.com/p/s/epidemiological-and-survival-analysis-of-hemangiosarcoma-in-the-last-twenty-years-1537
https://nccn.digitellinc.com/p/s/evaluation-of-aromatherapy-with-lavender-oil-during-the-perioperative-period-of-benignprostate-hyperplasia-a-randomized-placebo-controlled-clinical-observation-1538
https://nccn.digitellinc.com/p/s/improving-adherence-to-safe-handling-of-oral-hazardous-drugs-and-contaminated-wastes-1539
https://nccn.digitellinc.com/p/s/patient-experiences-and-perceptions-of-biomarker-testing-in-aml-and-cml-a-qualitative-analysis-1540
https://nccn.digitellinc.com/p/s/value-of-early-transfusion-burden-reduction-in-lower-risk-myelodysplastic-syndromes-1541
https://nccn.digitellinc.com/p/s/evaluating-kaposi-sarcoma-in-kidney-transplant-patients-a-systematic-review-and-meta-analysis-1542
https://nccn.digitellinc.com/p/s/partial-versus-radical-nephrectomy-an-age-wise-comparison-of-the-national-cancer-database-1543
https://nccn.digitellinc.com/p/s/intentional-weight-loss-and-associated-cancer-incidence-among-patients-with-overweight-or-obesity-a-systematic-literature-review-1544
https://nccn.digitellinc.com/p/s/role-of-cytoreductive-nephrectomy-in-metastatic-renal-cell-carcinoma-in-the-era-of-immunotherapy-an-analysis-of-the-national-cancer-database-ncdb-1545
https://nccn.digitellinc.com/p/s/oncological-outcome-of-multimodality-treatment-in-ewing-sarcoma-1546
https://nccn.digitellinc.com/p/s/real-world-clinical-outcomes-in-patients-with-advancedmetastatic-melanoma-and-brain-metastases-treated-with-pembrolizumab-monotherapy-an-analysis-of-the-adoreg-german-skin-cancer-registry-1547
https://nccn.digitellinc.com/p/s/analysis-of-risk-of-bone-fracture-and-osteoporosis-and-dual-energy-x-ray-absorptiometry-screening-rates-in-lung-cancer-survivors-with-and-without-bone-metastases-1548
https://nccn.digitellinc.com/p/s/a-comprehensive-examination-of-disparities-in-metastatic-breast-cancer-incidence-race-income-and-geography-1549
https://nccn.digitellinc.com/p/s/treatment-implications-of-expanded-genetic-testing-guidelines-for-patients-with-breast-cancer-a-retrospective-quality-review-1550
https://nccn.digitellinc.com/p/s/a-narrative-review-on-geriatric-assessment-and-outcomes-in-diffuse-large-b-cell-lymphoma-differentiating-fit-frail-and-unfit-patients-1551
https://nccn.digitellinc.com/p/s/10-years-experience-in-laparoscopic-gastrectomy-in-bogota-colombia-1552
https://nccn.digitellinc.com/p/s/temporary-toilet-lids-minimize-contamination-of-bathroom-surfaces-with-hazardous-drugs-1553
https://nccn.digitellinc.com/p/s/impact-of-obesity-on-sentinel-lymph-node-mapping-in-patients-with-endometrial-intraepithelial-neoplasia-undergoing-robotic-surgery-1554
https://nccn.digitellinc.com/p/s/clinical-and-epidemiological-characterization-of-the-oncologic-population-in-a-third-level-hospital-in-northeastern-mexico-1555
https://nccn.digitellinc.com/p/s/implementation-of-therapeutic-touch-in-an-ambulatory-palliative-oncology-clinic-1556
https://nccn.digitellinc.com/p/s/retrospective-analysis-of-30-day-readmission-risk-in-oncology-patients-1557
https://nccn.digitellinc.com/p/s/the-impact-of-prescription-drug-plan-part-d-enrollment-for-medicare-beneficiaries-on-eligibility-for-episodic-value-based-care-model-participation-and-total-cost-of-care-tcoc-at-a-community-oncology-n-1558
https://nccn.digitellinc.com/p/s/administration-of-goserelin-at-alternative-anatomical-sites-in-premenopausal-breast-cancer-1559
https://nccn.digitellinc.com/p/s/novel-therapies-in-the-oncology-care-model-a-profile-in-review-1560
https://nccn.digitellinc.com/p/s/the-role-of-obesity-in-influencing-patient-survival-in-metastatic-renal-cell-carcinoma-patients-receiving-immunotherapy-a-systematic-review-and-meta-analysis-1561
https://nccn.digitellinc.com/p/s/clinical-behavior-oncological-outcomes-and-external-validation-of-the-gronchi-nomogram-in-patients-diagnosed-with-primary-retroperitoneal-sarcoma-treated-at-a-latin-american-reference-center-between-2-1562
https://nccn.digitellinc.com/p/s/the-effect-of-exercise-on-cardiotoxicity-in-women-with-breast-cancer-receiving-anthracycline-based-chemotherapy-a-systematic-review-and-meta-analysis-1563
https://nccn.digitellinc.com/p/s/prevalence-of-anxiety-and-depression-in-newly-diagnosed-breast-cancer-patients-in-rural-minnesota-1564
https://nccn.digitellinc.com/p/s/association-between-primary-tumor-size-and-prognosis-in-denovo-metastatic-renal-cell-carcinoma-in-patients-who-underwent-first-line-immunotherapy-based-therapy-real-world-data-analysis-1565
https://nccn.digitellinc.com/p/s/real-world-effectiveness-of-erythropoiesis-stimulating-agents-after-luspatercept-in-patients-with-myelodysplastic-syndromes-a-retrospective-analysis-of-a-large-healthcare-claims-database-in-the-united-1566
https://nccn.digitellinc.com/p/s/mobile-health-mhealth-interventions-for-colorectal-cancer-crc-survivors-a-systematic-review-1567
https://nccn.digitellinc.com/p/s/reaching-unmet-needs-of-lung-cancer-patients-through-hope-totes-and-educational-meetings-1568
https://nccn.digitellinc.com/p/s/outcomes-with-sacituzumab-govitecan-in-metastatic-breast-cancer-a-systematic-review-and-meta-analysis-1569
https://nccn.digitellinc.com/p/s/outcomes-with-sacituzumab-govitecan-in-metastatic-breast-cancer-a-systematic-review-and-meta-analysis-1570
https://nccn.digitellinc.com/p/s/effects-of-a-music-based-intervention-on-reducing-compassion-fatigue-in-oncology-advanced-practice-providers-1571
https://nccn.digitellinc.com/p/s/determining-the-barriers-to-colonoscopy-in-patients-with-positive-cologuard-test-1572
https://nccn.digitellinc.com/p/s/casting-light-on-metastatic-kidney-cancer-survival-a-gender-based-examination-1573
https://nccn.digitellinc.com/p/s/unveiling-the-socioeconomic-gradient-income-linked-trends-in-metastatic-kidney-cancer-survival-1574
https://nccn.digitellinc.com/p/s/a-propensity-matched-survival-analysis-comparing-partial-versus-radical-nephrectomy-in-patients-with-metastatic-renal-cell-carcinoma-a-national-cancer-database-study-1575
https://nccn.digitellinc.com/p/s/outcome-of-positron-emission-tomography-computed-tomography-staging-in-breast-cancer-patients-having-neo-adjuvant-systemic-therapy-1576
https://nccn.digitellinc.com/p/s/empirical-study-to-estimate-real-world-impact-of-delay-in-adjuvant-treatment-on-healthcare-resource-utilization-and-cost-burden-1577
https://nccn.digitellinc.com/p/s/our-approach-to-patient-selection-for-polatuzumab-based-therapy-in-advanced-diffuse-large-b-cell-lymphoma-1578
https://nccn.digitellinc.com/p/s/evaluation-of-framework-for-colorectal-cancer-health-needs-assessment-in-north-and-central-asian-countries-1579
https://nccn.digitellinc.com/p/s/standalone-performance-evaluation-of-an-artificial-intelligence-breast-cancer-detection-tool-on-consecutively-collected-biopsy-proven-breast-cancer-and-screening-negative-tomosynthesis-cases-1580
https://nccn.digitellinc.com/p/s/precision-medicine-drivers-in-non-small-cell-lung-cancer-brain-metastases-1581
https://nccn.digitellinc.com/p/s/unifying-multimodal-data-time-series-analytics-and-contextual-medical-memory-introducing-minds-as-an-oncology-centric-cloud-based-platform-1582
https://nccn.digitellinc.com/p/s/determining-the-most-appropriate-fit-to-increasing-colorectal-cancer-screening-in-the-community-1583
https://nccn.digitellinc.com/p/s/pembrolizumab-induced-hemophagocytic-lymphohistiocytosis-in-a-patient-with-breast-cancer-a-case-report-and-systematic-review-of-the-literature-1584
https://nccn.digitellinc.com/p/s/immunotherapy-in-older-patients-with-breast-cancer-case-series-and-literature-review-1585
https://nccn.digitellinc.com/p/s/liver-ing-on-a-prayer-a-rare-case-of-hepatocellular-carcinoma-with-metastasis-to-the-thyroid-1586
https://nccn.digitellinc.com/p/s/navigating-the-challenges-of-nut-midline-carcinoma-a-case-study-and-therapeutic-insights-for-an-aggressive-oncologic-enigma-1587
https://nccn.digitellinc.com/p/s/effects-of-web-based-interventions-on-quality-of-life-among-patients-with-breast-cancer-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials-1588
https://nccn.digitellinc.com/p/s/response-to-dabrafenib-and-trametinib-in-a-patient-with-an-uncommon-activating-braf-mutation-a-first-in-metastatic-non-small-cell-lung-cancer-1589
https://nccn.digitellinc.com/p/s/hemochromatosis-in-an-adult-female-with-previous-iron-deficiency-anemia-on-iron-supplementation-1590
https://nccn.digitellinc.com/p/s/unmasking-the-unpredictable-spontaneous-tumor-lysis-syndrome-in-metastatic-breast-cancer-a-case-beyond-expectations-1591
https://nccn.digitellinc.com/p/s/extrapulmonary-small-cell-carcinoma-of-gallbladder-presenting-as-acute-cholecystitis-1592
https://nccn.digitellinc.com/p/s/complete-remission-of-microsatellite-instability-high-msi-h-oligometastatic-poorly-differentiated-colon-adenocarcinoma-after-a-single-dose-of-immunotherapy-1593
https://nccn.digitellinc.com/p/s/successful-management-of-locally-advanced-and-oligometastatic-urothelial-carcinoma-with-pembrolizumab-based-induction-regimen-followed-by-consolidative-radical-resection-of-the-primary-tumor-a-multi-i-1594
https://nccn.digitellinc.com/p/s/neuroendocrine-tumor-of-the-gallbladder-a-case-report-and-literature-review-1595
https://nccn.digitellinc.com/p/s/preoperative-assessment-of-vulvar-melanoma-surgical-margins-using-in-vivo-reflectance-confocal-microscopy-1596
https://nccn.digitellinc.com/p/s/gluteal-metastasis-of-intrahepatic-cholangiocarcinoma-clinical-case-and-literature-review-1597
https://nccn.digitellinc.com/p/s/microgranular-acute-promyelocytic-leukemia-presenting-as-recurrent-stroke-and-isolated-neutropenia-1598
https://nccn.digitellinc.com/p/s/social-determinants-of-health-in-real-world-evidence-studies-of-early-stage-cancercare-a-systematic-literature-review-1599
https://nccn.digitellinc.com/p/s/a-rare-case-of-immune-checkpoint-inhibitor-induced-seronegative-myasthenia-gravis-1600
https://nccn.digitellinc.com/p/s/microangiopathic-hemolytic-anemia-as-the-presenting-manifestation-of-metastatic-breast-cancer-1601
https://nccn.digitellinc.com/p/s/rare-case-of-a-paraneoplastic-cerebellar-ataxia-secondary-to-a-retroperitoneal-neuroendocrine-tumor-of-unknown-origin-1602
https://nccn.digitellinc.com/p/s/hyperfibrinolysis-as-the-primary-presenting-sign-of-metastatic-prostate-cancer-a-diagnostic-challenge-1603
https://nccn.digitellinc.com/p/s/brown-fat-adipose-tissue-bat-activation-mimicking-lymphoma-associated-lymphadenopathy-1604
https://nccn.digitellinc.com/p/cf/2024-annual-conference-nursing-1605
https://nccn.digitellinc.com/p/s/breakfast-and-registration-1606
https://nccn.digitellinc.com/p/s/opening-remarks-1607
https://nccn.digitellinc.com/p/s/updates-on-safe-handling-1608
https://nccn.digitellinc.com/p/s/a-model-for-responding-to-chemotherapy-infusion-hypersensitivity-reactions-1609
https://nccn.digitellinc.com/p/s/break-1610
https://nccn.digitellinc.com/p/s/management-of-colorectal-cancer-1611
https://nccn.digitellinc.com/p/s/bispecific-antibodies-a-new-frontier-in-immunotherapy-1612
https://nccn.digitellinc.com/p/s/current-treatment-approaches-for-transformed-indolent-b-cell-lymphomas-1613
https://nccn.digitellinc.com/p/s/lunch-1614
https://nccn.digitellinc.com/p/s/pain-management-in-oncology-1615
https://nccn.digitellinc.com/p/s/cancer-care-of-the-lgbtq-plus-community-nursing-perspectives-1616
https://nccn.digitellinc.com/p/s/networking-reception-1617
https://nccn.digitellinc.com/p/cf/2024-annual-conference-1618
https://nccn.digitellinc.com/p/s/welcoming-remarks-1621
https://nccn.digitellinc.com/p/s/plenary-session-living-with-lynch-syndrome-a-patient-story-1622
https://nccn.digitellinc.com/p/s/management-of-msi-hdmmr-upper-and-lower-gastrointestinal-cancers-1625
https://nccn.digitellinc.com/p/s/changing-economics-in-cancer-care-optimizing-resources-and-strategic-tactics-to-improve-patient-outcomes-and-protect-the-workforce-1626
https://nccn.digitellinc.com/p/s/acute-myeloid-leukemia-role-of-flt3-inhibitors-after-allogeneic-hematopoietic-cell-transplantation-1627
https://nccn.digitellinc.com/p/s/high-risk-prevention-programs-identifying-services-for-high-risk-patients-1628
https://nccn.digitellinc.com/p/s/non-ce-product-theater-matters-of-the-heart-diagnosing-and-treating-light-chain-amyloidosis-al-1632
https://nccn.digitellinc.com/p/s/updates-to-the-management-of-multiple-myeloma-1633
https://nccn.digitellinc.com/p/s/the-evolving-role-of-advanced-practice-providers-in-oncology-care-1634
https://nccn.digitellinc.com/p/s/updates-in-the-management-of-locally-advanced-rectal-cancer-1635
https://nccn.digitellinc.com/p/s/successful-team-care-models-allocation-of-responsibilities-and-team-metrics-1636
https://nccn.digitellinc.com/p/s/team-based-case-review-colorectal-cancer-1639
https://nccn.digitellinc.com/p/s/nccn-foundation-young-investigator-awards-oral-poster-presentation-1641
https://nccn.digitellinc.com/p/s/registration-breakfast-exhibits-and-general-poster-session-1643
https://nccn.digitellinc.com/p/s/nccn-foundation-empowering-patients-and-research-innovation-1644
https://nccn.digitellinc.com/p/s/plenary-session-promising-practices-to-reduce-the-impact-of-drug-shortages-on-cancer-care-1645
https://nccn.digitellinc.com/p/s/break-exhibits-and-general-poster-session-1646
https://nccn.digitellinc.com/p/s/continue-the-conversation-reducing-the-impact-of-drug-shortages-1647
https://nccn.digitellinc.com/p/s/new-targeted-therapies-for-metastatic-non-small-cell-lung-cancer-1648
https://nccn.digitellinc.com/p/s/balancing-inpatient-and-outpatient-oncology-care-1649
https://nccn.digitellinc.com/p/s/appropriate-vaccinations-for-patients-in-survivorship-1650
https://nccn.digitellinc.com/p/s/collection-and-utilization-of-sexsex-characteristics-sexual-orientation-and-gender-identity-ssogi-data-1651
https://nccn.digitellinc.com/p/s/lunch-exhibits-and-general-poster-session-1652
https://nccn.digitellinc.com/p/s/non-ce-product-theater-understanding-the-role-of-advanced-practice-providers-in-the-management-of-low-risk-myelodysplastic-syndromes-mds-1653
https://nccn.digitellinc.com/p/s/follow-the-expert-guided-poster-tour-1654
https://nccn.digitellinc.com/p/s/non-ce-product-theater-expanding-options-for-patients-with-her2-low-mbc-1655
https://nccn.digitellinc.com/p/s/management-of-trauma-related-and-stressor-related-disorders-1656
https://nccn.digitellinc.com/p/s/artificial-intelligence-in-oncology-1657
https://nccn.digitellinc.com/p/s/variations-in-breast-cancer-screening-recommendations-1658
https://nccn.digitellinc.com/p/s/best-practices-in-care-team-communication-technology-1659
https://nccn.digitellinc.com/p/s/break-exhibits-and-general-poster-session-1660
https://nccn.digitellinc.com/p/s/updates-to-the-management-of-hr-positive-her2-negative-breast-cancer-1661
https://nccn.digitellinc.com/p/s/improving-infusion-efficiency-to-optimize-oncology-care-1662
https://nccn.digitellinc.com/p/s/team-based-case-review-breast-cancer-1663
https://nccn.digitellinc.com/p/s/continue-the-conversation-breast-cancer-1664
https://nccn.digitellinc.com/p/s/updates-in-oncology-oral-presentations-from-the-nccn-poster-sessions-1665
https://nccn.digitellinc.com/p/s/registration-and-breakfast-1666
https://nccn.digitellinc.com/p/s/management-of-renal-cell-carcinoma-1667
https://nccn.digitellinc.com/p/s/updates-in-the-treatment-of-metastatic-urothelial-cancer-1668
https://nccn.digitellinc.com/p/s/risk-stratification-and-selection-of-management-strategy-for-localized-prostate-cancer-1669
https://nccn.digitellinc.com/p/s/break-1670
https://nccn.digitellinc.com/p/s/updates-to-the-management-of-endometrial-cancer-1671
https://nccn.digitellinc.com/p/s/updates-to-the-management-of-cutaneous-melanoma-1672
https://nccn.digitellinc.com/p/s/basal-cell-and-squamous-cell-skin-cancers-nccn-guidelines-r-updates-based-on-risk-status-1673
https://nccn.digitellinc.com/p/s/cancer-risk-reduction-strategies-for-transgender-non-binary-and-gender-diverse-people-with-hereditary-cancer-syndromes-1674
https://nccn.digitellinc.com/p/s/capturing-structured-data-in-the-electronic-health-record-1675
https://nccn.digitellinc.com/p/s/management-of-cancer-related-fatigue-1676
https://nccn.digitellinc.com/p/s/updates-in-the-management-of-neuroblastoma-1677
https://nccn.digitellinc.com/p/s/updates-in-clinical-management-of-pancreatic-cancer-1678
https://nccn.digitellinc.com/p/s/updates-to-treatment-of-recurrentmetastatic-head-and-neck-cancers-1679
https://nccn.digitellinc.com/p/s/updates-in-the-management-of-small-cell-lung-cancer-1680
https://nccn.digitellinc.com/p/s/delays-in-adjuvant-therapy-in-head-and-neck-cancers-identifying-clinical-and-population-disparities-1683
https://nccn.digitellinc.com/p/s/mingle-for-a-mission-1684